Cannabis (THC) cures Cancer at early prognose:
Progressive tumor reduction:
Progressive tumor reduction with woman in her 80's:
Doctors in the United Kingdom recently published an article in the journal BMJ Case Reports. The case report describes a woman in her 80s with lung cancer who experienced tumor regression while taking CBD oil.
She also has a history of chronic obstructive pulmonary disease, high blood pressure, and osteoarthritis and received medications to treat these conditions.
The woman reported smoking just over a pack of cigarettes per week, or 68 packs per year, before and after diagnosis. In June and July 2018, doctors examined the woman, which included a CT scan, a PET scan, an MRI scan, and a biopsy, to stage and confirm the diagnosis.
The doctors reached a diagnosis of stage IIBTrusted Source non-small cell lung cancer (NSCLC). The initial CT scan showed a 41-millimeter (mm), or 1.6-inch (in), nodule in the middle lobeTrusted Source of the woman's right lung.
Testing revealed no lymph node involvement or metastases, which is when cancer spreads to other parts of the body. For this reason, the doctors recommended curative treatment.
Treatment for NSCLC may include surgery, radiofrequency ablationTrusted Source, chemotherapy, targeted therapy, and immunotherapy.
The doctors repeated the chest CT scan in September 2018, which showed a reduction of the right middle lobe cancer to 33 mm (1.3 in), and two new nodules in the left apex and right upper lobe.
The woman declined surgical removal of the lobe due to the risks of surgery. She also declined treatment with radiofrequency ablation because of the side effects that her late husband had experienced from radiation therapy.
The doctors decided to monitor the patient, conducting CT scans every 3-6 months. During the 2.5-year follow-up period, CT scans showed a progressive decrease of the initial right middle lobe nodule from 41 mm (1.6 in) in June 2018 to 10 mm (0.4 in) in February 2021.
At this time, the woman revealed she started taking CBD oil at a dose of 0.5 milliliters orally three times daily, and occasionally twice daily, shortly after her diagnosis.
The active ingredients specified by the supplier were THC (19.5%), CBD (20.05%), and tetrahydrocannabinolic acid (23.8%).
Upon the supplier's advice, the woman did not take the CBD oil with hot food or drinks, because she wanted to avoid "feeling stoned." She reported decreased appetite while taking CBD oil.
The woman did not change her diet, lifestyle, or prescribed medications during this time. She also reported continuing to smoke one pack of cigarettes per week during the surveillance period.
Proof of How Marijuana Cures Cancer
Study: THC and another cannabinoid called cannabinol (CBN) slowed the growth of lung cancer in mice
Rick Simpson decided to try cannabis oil after reading the results of a 1975 studyTrusted Source that tested the use of cannabinoids in mice with lung cancer. The study found that both THC and another cannabinoid called cannabinol (CBN) slowed the growth of lung cancer in mice. https://www.healthline.com/health/rick-simpson-oil-cancer#research
"A major discovery in cancer in cannabinoid use in cancer treatment is its ability in targeted killing of tumors. Several preclinical studies suggest that Δ9-THC, other naturally occurring cannabinoids, synthetic cannabinoid agonists and endocannabinoids have anti-cancer effects in vitro against lung carcinoma, gliomas, thyroid epithelioma, lymphoma, skin carcinoma, uterine carcinoma, breast cancer, prostate carcinoma, pancreatic cancer and neuroblastoma . These findings were also supported by in vivo studies and the majority of effects of cannabinoids are mediated via CB1 and CB2."
"On the other hand, the authors of a 2015 study in men found a promising relationship between cannabis and bladder cancer. After adjusting for several factors, they found that participants who used cannabis had a 45% lower risk of developing bladder cancer."
"In 2016, scientists concluded that cannabinoids show promise in the fight against cancer after determining that these compounds inhibited the growth of many types of tumor cell in test tube and animal models."
"In cancer patients, cannabinoids have primarily been used as a part of palliative care to alleviate pain, relieve nausea and stimulate appetite [8,20]. In addition, numerous cell culture and animal studies showed antitumor effects of cannabinoids and suggested new therapeutic opportunities for cancer patients" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387667/